Skip to main content
Erschienen in: Indian Journal of Pediatrics 5/2024

28.07.2023 | Original Article

Recurrent Guillain-Barré Syndrome: Clinical Profile and Outcome

verfasst von: K. C. Sudeep, Arun Bansal, Manjinder Singh Randhawa, Jayashree Muralidharan, Karthi Nallasamy, Suresh Kumar Angurana, Naveen Sankhyan

Erschienen in: Indian Journal of Pediatrics | Ausgabe 5/2024

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To compare clinical, neurological, treatment and outcome of recurrent Guillian-Barré Syndrome (GBS) with non-recurrent GBS. Also, to compare different episodes of recurrent GBS.

Methods

The patient's case records were retrieved retrospectively from the electronic database and case record files. Clinical profile, nerve conduction study, treatment, and outcome details of children with a diagnosis of GBS admitted in Pediatric Intensive Care Unit (PICU) from 2010 to March 2022 were screened. Recurrent GBS cases, as defined by the National Institute of Neurological and Communicative Diseases and Strokes (NINCDS) criteria, were analysed separately. The comparison was made between the first episode of recurrent GBS with non-recurrent GBS, and predictors of recurrence were identified. A comparison of course and outcome was also done between different episodes of GBS in recurrent cases.

Results

Recurrent GBS was observed in 11 (4.7%) out of 234 cases during the study period. The presence of respiratory (p 0.015) and gastrointestinal illness (p 0.007) as preceding illnesses were associated with recurrence. No difference was noted between the first episode of recurrent GBS and non-recurrent GBS. The first and second episodes of GBS in 11 recurrent cases were similar in course and outcome.

Conclusions

Recurrent GBS is underreported but a known entity. No difference was seen between the two episodes of recurrent GBS. However, more data is required to find the features of recurrent GBS so that limited PICU resources can be used judiciously and intervention planned accordingly.
Literatur
1.
Zurück zum Zitat Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol. 1990;27:S21–4.CrossRefPubMed Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol. 1990;27:S21–4.CrossRefPubMed
2.
Zurück zum Zitat Kuitwaard K, van Koningsveld R, Ruts L, Jacobs BC, van Doorn PA. Recurrent Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 2009;80:56–9.CrossRefPubMed Kuitwaard K, van Koningsveld R, Ruts L, Jacobs BC, van Doorn PA. Recurrent Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 2009;80:56–9.CrossRefPubMed
3.
Zurück zum Zitat Kuitwaard K, Bos-Eyssen ME, Blomkwist-Markens PH, van Doorn PA. Recurrences, vaccinations and long-term symptoms in GBS and CIDP. J Peripher Nerv Syst. 2009;14:310–5.CrossRefPubMed Kuitwaard K, Bos-Eyssen ME, Blomkwist-Markens PH, van Doorn PA. Recurrences, vaccinations and long-term symptoms in GBS and CIDP. J Peripher Nerv Syst. 2009;14:310–5.CrossRefPubMed
4.
Zurück zum Zitat Notturno F, Kokubun N, Sekiguki Y, et al. Demyelinating Guillain-Barré syndrome recurs more frequently than axonal subtypes. J Neurol Sci. 2016;365:132–6.CrossRefPubMed Notturno F, Kokubun N, Sekiguki Y, et al. Demyelinating Guillain-Barré syndrome recurs more frequently than axonal subtypes. J Neurol Sci. 2016;365:132–6.CrossRefPubMed
5.
Zurück zum Zitat Das A, Kalita J, Misra UK. Recurrent Guillain Barré syndrome. Electromyogr Clin Neurophysiol. 2004;44:95–102.PubMed Das A, Kalita J, Misra UK. Recurrent Guillain Barré syndrome. Electromyogr Clin Neurophysiol. 2004;44:95–102.PubMed
6.
Zurück zum Zitat Taly AB, Gupta SK, Anisya V, et al. Recurrent Guillain Barré syndrome: A clinical, electrophysiological and morphological study. J Assoc Physicians India. 1995;43:249–52.PubMed Taly AB, Gupta SK, Anisya V, et al. Recurrent Guillain Barré syndrome: A clinical, electrophysiological and morphological study. J Assoc Physicians India. 1995;43:249–52.PubMed
7.
Zurück zum Zitat Grand’Maison F, Feasby TE, Hahn AF, Koopman WJ. Recurrent Guillain-Barré syndrome. Clinical and laboratory features. Brain J Neurol. 1992;115:1093–106. Grand’Maison F, Feasby TE, Hahn AF, Koopman WJ. Recurrent Guillain-Barré syndrome. Clinical and laboratory features. Brain J Neurol. 1992;115:1093–106.
8.
Zurück zum Zitat Baba M, Matsunaga M, Narita S, Liu H. Recurrent Guillain-Barré syndrome in Japan. Intern Med Tokyo Jpn. 1995;34:1015–8.CrossRef Baba M, Matsunaga M, Narita S, Liu H. Recurrent Guillain-Barré syndrome in Japan. Intern Med Tokyo Jpn. 1995;34:1015–8.CrossRef
9.
Zurück zum Zitat Basta I, Bozovic I, Berisavac I, et al. Recurrent Guillain-Barré Syndrome - Case series. Neurol India. 2019;67:1536–8.CrossRefPubMed Basta I, Bozovic I, Berisavac I, et al. Recurrent Guillain-Barré Syndrome - Case series. Neurol India. 2019;67:1536–8.CrossRefPubMed
10.
Zurück zum Zitat Pyun SY, Jeong JH, Bae JS. Recurrent Guillain-Barré syndrome presenting stereotypic manifestations, positive antiganglioside antibodies, and rapid recovery. Clin Neurol Neurosurg. 2015;139:230–3.CrossRefPubMed Pyun SY, Jeong JH, Bae JS. Recurrent Guillain-Barré syndrome presenting stereotypic manifestations, positive antiganglioside antibodies, and rapid recovery. Clin Neurol Neurosurg. 2015;139:230–3.CrossRefPubMed
11.
Zurück zum Zitat Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial prednisolone in acute polyneuropathy. Lancet. 1978;2:750–3.CrossRefPubMed Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial prednisolone in acute polyneuropathy. Lancet. 1978;2:750–3.CrossRefPubMed
12.
Zurück zum Zitat Kleyweg RP, van der Meché FG. Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange. J Neurol Neurosurg Psychiatry. 1991;54:957–60.CrossRefPubMedPubMedCentral Kleyweg RP, van der Meché FG. Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange. J Neurol Neurosurg Psychiatry. 1991;54:957–60.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Ruts L, van Koningsveld R, van Doorn PA. Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuations. Neurology. 2005;65:138–40.CrossRefPubMed Ruts L, van Koningsveld R, van Doorn PA. Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuations. Neurology. 2005;65:138–40.CrossRefPubMed
14.
Zurück zum Zitat Willison HJ. The immunobiology of Guillain-Barré syndromes. J Peripher Nerv Syst. 2005;10:94–112.CrossRefPubMed Willison HJ. The immunobiology of Guillain-Barré syndromes. J Peripher Nerv Syst. 2005;10:94–112.CrossRefPubMed
15.
Zurück zum Zitat Mossberg N, Nordin M, Movitz C, et al. The recurrent Guillain-Barré syndrome: A long-term population-based study. Acta Neurol Scand. 2012;126:154–61.CrossRefPubMed Mossberg N, Nordin M, Movitz C, et al. The recurrent Guillain-Barré syndrome: A long-term population-based study. Acta Neurol Scand. 2012;126:154–61.CrossRefPubMed
16.
Zurück zum Zitat Jacobs BC, Rothbarth PH, van der Meché FG, et al. The spectrum of antecedent infections in Guillain-Barré syndrome: A case-control study. Neurology. 1998;51:1110–5.CrossRefPubMed Jacobs BC, Rothbarth PH, van der Meché FG, et al. The spectrum of antecedent infections in Guillain-Barré syndrome: A case-control study. Neurology. 1998;51:1110–5.CrossRefPubMed
17.
Zurück zum Zitat Randhawa MS, Iyer R, Bansal A, et al. Clinical features associated with need for mechanical ventilation in children with Guillain-Barré syndrome: Retrospective cohort from India. Pediatr Crit Care Med. 2022;23:378–82.CrossRefPubMed Randhawa MS, Iyer R, Bansal A, et al. Clinical features associated with need for mechanical ventilation in children with Guillain-Barré syndrome: Retrospective cohort from India. Pediatr Crit Care Med. 2022;23:378–82.CrossRefPubMed
Metadaten
Titel
Recurrent Guillain-Barré Syndrome: Clinical Profile and Outcome
verfasst von
K. C. Sudeep
Arun Bansal
Manjinder Singh Randhawa
Jayashree Muralidharan
Karthi Nallasamy
Suresh Kumar Angurana
Naveen Sankhyan
Publikationsdatum
28.07.2023
Verlag
Springer India
Erschienen in
Indian Journal of Pediatrics / Ausgabe 5/2024
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-023-04746-y

Weitere Artikel der Ausgabe 5/2024

Indian Journal of Pediatrics 5/2024 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.